Архив отчётов
Вся аналитика
Страница 23 из 52 · 1235 отчётов
47/100
Novonesis A/S (NSIS-B.CO) Zen Horizon Research Report
Novonesis A/S (NSIS-B.CO) is a Copenhagen-listed Danish biotechnology platform leader formed in January 2024 through the merger of Novozymes, the global leader in industrial enzymes, and Chr. Hansen, the global leader in probiotics, with FY2025 revenue of DKK 32,376M and an adjusted EBITDA margin of 37.1%. Its two divisions span Food & Health, built around probiotics, enzymes, and the microbiome, and Planetary Health, built around industrial enzymes, feed, and agricultural biosolutions, while Novo Holdings controls 25.5% of the economics and 63.35% of the votes. Research rating Watch: a high-quality compounder with merger synergies already delivered, but the current valuation is near the upper end of fair value and leaves limited margin of safety against EUR/USD pressure and integration risk.
48/100
Lattice Semiconductor (LSCC.US) Zen Horizon Research Report
Lattice Semiconductor (LSCC.US) is now the world’s only major independent FPGA leader after AMD acquired Xilinx in 2022 and Intel separated Altera in 2025, with a focus on low-power FPGA for Edge AI, communications and computing, industrial, and automotive safety applications. FY2025 revenue was $523.3M at the inventory-cycle trough, non-GAAP EPS was $1.05, and Q1 2026 revenue reached a record $170.9M, up 42% YoY, while new CEO Ford Tamer, former Inphi CEO for 9 years, is pushing incremental growth in Edge AI and data centers. Research rating Watch: at $142.15, a $19.5B market cap, 74x forward PE, and a 52-week gain of +198%, valuation has already discounted a near-perfect scenario.
45/100
86Buffett
Givaudan SA (GIVN.SW) Zen Horizon Research Report
Givaudan SA (GIVN.SW), headquartered in Geneva and tracing its roots to 1768, is the global leader in flavors and fragrances, with FY2025 revenue of CHF 7,472M, comparable EBITDA margin of 24.2%, and net income of CHF 1,071M. Its two-pillar Fragrance & Beauty plus Taste & Wellbeing business holds roughly 25% global share, while the oligopoly with IFF, Firmenich, and Symrise controls at least 53% of the market, but the key variables are the CEO handover after a 20-year tenure and the Q1 2026 slowdown in Taste. Research rating Watch: a high-quality GDP-plus compounder, but the current price already prices in much of the quality while the CEO transition and Taste deceleration still need evidence.
51/100
50Buffett
Eurofins Scientific (Eurofins Scientific SE, ERF.PA) — Zen Horizon Report
Eurofins Scientific, founded in 1987 by Gilles Martin in Nantes, France and headquartered in Luxembourg, is the world's largest testing, inspection and certification (TIC) leader, spanning food, environment, pharma, clinical diagnostics and consumer products, with roughly 64,000 employees and 900+ laboratories across 50+ countries; FY2025 revenue was EUR 7.30 B (+5.0% reported / +4.1% organic), adjusted EBITDA margin 22.5% (mature business 24.3%) and EPS EUR 2.31 (+24%), while the Martin family holds 32.9% economic interest / 65.8% voting power through Analytical Bioventures. Following Muddy Waters' June 2024 short report alleging self-dealing—which the company fully rebutted—the market's governance discount has yet to fully clear. Rating Watch: a high-quality TIC leader that is reasonably-to-richly valued and awaits a pullback rather than entry at the current price.
45/100
Renishaw plc (RSW.LSE) Zen Horizon Research Report
Renishaw is a Gloucestershire, UK-based precision metrology and industrial automation leader founded in 1973 by two former Rolls-Royce engineers, the original inventor and global No. 1 standard-setter in coordinate measuring machine (CMM) touch-trigger probes, with 94% of revenue from manufacturing technologies and 6% from analytical instruments and medical devices. FY2025 revenue was £713M, adjusted operating margin was 15.7%, adjusted profit before tax was £127.2M, and FY2026 H1 accelerated to +11.5% at constant currency on structural semiconductor and defense demand; after founder Sir David McMurtry died in December 2024, the McMurtry/Deer families formed Deltam Holdings in 2025 with a 50.25% stake, completing generational succession and ending the sale process. Research rating Watch: a high-quality UK hidden champion whose valuation already discounts much of the 20% margin and semiconductor-defense supercycle upside.
44/100
38Buffett
Vestas Wind Systems A/S (VWS.CO) Zen Horizon Research Report
Vestas Wind Systems A/S is the global No. 1 wind turbine OEM outside China, headquartered in Aarhus, Denmark, founded in 1898 and manufacturing wind turbines since 1979; 2025 revenue was EUR 18.8 B, with Power Solutions contributing 81% through onshore and offshore turbine sales and Service contributing 19% through 15-25 year long-term O&M contracts. Its 192 GW cumulative installed base equals 23% of global wind capacity, placing it in the top-three structure alongside China's Goldwind and Siemens Gamesa, while margins have recovered from -7.6% to +5.7% after the 2021-2024 supply-chain, inflation, and offshore-quality crisis, with management targeting an EBIT margin of at least 10% by 2030. Research rating Cautious Buy: a high-quality wind OEM with a Service annuity moat and a clear long-term margin-recovery path, but position building should be staged given policy and execution risks.
48/100
Lonza Group AG (LONN.SW) Zen Horizon Research Report
Lonza Group is a Basel-based Swiss biopharmaceutical CDMO founded in 1897 and now the world's second-largest biologics manufacturing outsourcer, with 2025 revenue of CHF 6.53B split between Biologics (70%, mAb / ADC / CGT / mRNA manufacturing) and Capsules & Health Ingredients (30%). The core thesis is that its 2024 strategic reset, including the USD 1.2B acquisition of Roche's Vacaville site in California, the divestiture of Specialty Ingredients, and the arrival of CEO Wolfgang Wienand, positions Lonza as one of only two scaled mammalian biologics capacity leaders above 200,000L, alongside Samsung Biologics, with additional policy tailwinds from the BIOSECURE Act against WuXi Biologics. Rating Hold: a high-quality CDMO compounder with visible recovery and upside catalysts, but a thin margin of safety at the current price.
51/100
49Buffett
Safran SA (SAF.PA) — Zen Horizon Report
Safran is France's leading narrowbody aero-engine champion, co-owning CFM International 50/50 with GE Aerospace (the CFM56/LEAP family powers the Boeing 737 MAX and Airbus A320neo, with roughly 75% share including the JV); 2025 revenue was €31.2B, split 78% civil aviation and 22% defense, with the aftermarket annuity (23,000 CFM56 plus 7,500 LEAP units in service) at the core of profit; defense has lately accelerated on France's LPM 2024-2030 act, and the CFM partnership with GE was renegotiated in 2025 to run through 2050. Rating Watch: a high-quality narrowbody-aftermarket annuity asset whose current price already fully discounts the roadmap, leaving thin margin of safety for new positions.
34/100
NuScale Power (SMR): Zen Horizon Research Report
NuScale Power is the world's first small modular reactor (SMR) pure-play to win a U.S. NRC-approved design certification, spun out of Oregon State University's IRIS project in 2007 and listed via SPAC in 2022; each SMR module is rated at 77 MWe and a typical multi-module plant runs 924 MWe. But the early-2024 cancellation of its flagship CFPP/UAMPS project gutted the commercial outlook, with TTM revenue of just $18.7M, Q1 revenue down 95.8% year over year, an operating margin of -101%, and a commercial deployment window no earlier than the 2030s. At the current $10.50 share price (down 70% over the past year), the implied 195x P/S still leaves valuation badly overextended. Rating Avoid: a compelling story is not a good investment, and the gap between narrative and fundamentals has reached an unsustainable level.
46/100
78Buffett
Novartis (NVS) Zen Horizon Research Report
Novartis is one of the world's top ten innovative pharmaceutical companies, headquartered in Basel, Switzerland, and has repositioned itself as a pure-play innovative medicines company after spinning off Sandoz in October 2023. Its portfolio spans cardiovascular, oncology, immunology, neuroscience, and rare diseases, supported by 2025 revenue of about $56.6 billion, a 30% operating margin, roughly $15 billion in free cash flow, and 28 consecutive years of dividend increases, while Entresto's U.S. generic entry in Q4 2025 remains the key near-term challenge. Research rating Hold: a high-quality defensive compounder with a deep moat, but the current price already reflects neutral expectations and leaves limited margin of safety.
44/100
72Buffett
Quanta (2382.TW) Zen Horizon Research Report
Quanta Computer, founded by Barry Lam in 1988, is the world's largest notebook ODM and has transformed in recent years into the world's second-largest AI server rack-scale ODM, behind only Foxconn, manufacturing NVIDIA GB200/GB300 systems for customers including Google, Meta, and AWS. In 2026Q1, servers accounted for more than 80% of revenue, revenue grew 66.6% year over year, and quarterly gross margin fell to 4.78%. Research rating Hold: a genuine AI infrastructure compounder, but margin quality, cash flow pressure, and valuation leave too little margin of safety at the current price.
48/100
49Buffett
Rolls-Royce (RR.LSE) Zen Horizon Research Report
Rolls-Royce is a UK national-champion industrial group spanning aero engines, marine power, power systems, and nuclear power, including civilian SMRs and military submarine propulsion. After its share price fell to 70p in 2022 and the company approached distress, new CEO Tufan Erginbilgiç launched the aggressive "burning platform" restructuring in early 2023, driving the share price to 1260p within three years, an 18-fold rise. Research rating Hold: a high-quality turnaround and strategic nuclear option, but the current valuation has already priced in most of the good news.
46/100
48Buffett
nVent Electric (NVT) Zen Horizon Research Report
nVent is an electrical infrastructure supplier spun out of Pentair in 2018, with core businesses in data-center IT racks, liquid-cooling CDU/RDHx systems, modular data-center buildings through Trachte, and medium- and low-voltage switchgear through Avail EPG. The core thesis is that nVent has recycled capital out of mature thermal-management assets and into AI data-center picks and shovels, with fiscal 2024 revenue of about $3.35 billion and an operating margin near 20%. Report rating Hold: a high-quality compounder, but the current valuation already prices in most of the AI data-center upside.
37/100
Oklo (OKLO.US) Zen Horizon Research Report
Oklo is an advanced nuclear fission developer founded in 2013 by two MIT nuclear engineering PhDs and taken public on the NYSE in 2024 through Sam Altman's SPAC, with its sodium-cooled fast reactor Aurora (75 MWe) and a build-own-operate model that sells power rather than reactors to AI data centers under long-term PPAs. The core thesis is real policy access and real cash, but a pre-revenue company with a Q1 2026 net loss of $33M, $2.54B of cash, and DOE reactor-pilot selection is already carrying a very long-dated option value. Report Rating Watch: an excellent story with no margin of safety at the current price.
39/100
Navitas Semiconductor (NVTS.US) Zen Horizon Research Report
Navitas (NVTS) is a small fabless wide-bandgap power semiconductor company founded in California in 2014, listed via SPAC in 2021, and expanded into high-voltage SiC through the $100M GeneSiC acquisition in 2022. Its two product lines, GaNFast integrated ICs and GeneSiC SiC MOSFETs, span 80V to 3300V and target AI data-center 800V HVDC, energy infrastructure, high-performance computing, industrial electrification, and mobile charging. Report rating Underweight: NVIDIA's 800V HVDC partnership is real, but the valuation already prices in an optimistic Kyber 2027 ramp, dominant NVTS share, and an AI narrative premium.
49/100
Hesai Group (HSAI) Zen Horizon Research Report
Hesai Group is the global leader in automotive lidar, founded in Shanghai in 2014, listed on Nasdaq in 2023, and dual-primary listed in Hong Kong in 2025. As a pure-play lidar hardware supplier, its products span ADAS factory installation, Robotaxi/L4, and robotics, with customers including 40 auto brands and most of the world's leading Robotaxi companies. Research rating Watch: 2025 shipments reached 1.62 million units, revenue was about $433 million, or roughly RMB3.0 billion, and Hesai became the world's first lidar company to deliver full-year GAAP profitability, yet weak earnings quality, slowing growth, and binary U.S. regulatory tail risk keep the stock below a Buy threshold.
43/100
39Buffett
Agnico Eagle Mines (AEM) Zen Horizon Report
Agnico Eagle Mines (AEM, dual-listed on NYSE/TSX and reporting in USD) is the world's second-largest gold miner and widely regarded as one of the highest-quality operators, with about 3.45 million ounces of 2025 gold production, senior-producer-low AISC of about $1,339/oz, roughly 97% of output from tier-A mining jurisdictions such as Canada, Australia, and Finland, and gold as its overwhelmingly dominant business. Its balance sheet is net cash at about $2.9 billion, total debt is only about $200 million, Fitch upgraded it to A- in April 2026, and 2025 free cash flow reached a record of about $4.4 billion, but the stock is now in the part of the cycle where spot gold has corrected from its late-January 2026 intraday record of about $5,589/oz and AEM has fallen about 35% from its March 2, 2026 high of $251.57. Report rating Watch: downside risk is conditional on a further gold-price decline, with an ideal buy price at or below $135; this stands against sell-side Buy consensus and an average target of $254, but the real wager on both sides is the gold price, which no one can forecast reliably.
41/100
Liuliumei (06658.HK) Zen Horizon Report
Liuliumei, or Liuliumei Orchard Group, is China's category leader in green-plum and plum-based snacks, ranking first in 2024 China retail sales of plum products, fruit snacks, and natural-ingredient jelly with market shares of 7.0%, 4.9%, and 45.7%. The company is listing in Hong Kong at a fixed offer price of HK$43.58 on 2026-06-15, offering about 11.46 million H shares globally, raising net proceeds of about HK$440 million, and at one point drawing margin oversubscription of more than 240x on the first day. Research rating Watch: a real profitable niche leader, but slowing growth, weakening gross margin, deteriorating cash flow, and governance issues leave valuation as the only meaningful support.
51/100
Snowflake (SNOW.US) Zen Horizon Report
Snowflake is the leading consumption-priced cloud data platform, delivering its first reacceleration after two years of decelerating growth: FY2027 Q1 (ended 2026-04-30) product revenue of $1.334 billion (+34% YoY), net revenue retention (NRR) back up to 126%, and remaining performance obligations (RPO) of $9.21 billion (+38%). Financial quality is excellent, with an adjusted free cash flow margin of 25.5% and net cash of +$2.11 billion; but it still posts an annual GAAP loss of $1.33 billion and stock-based compensation runs at 34% of revenue. Rating Watch: a high-quality business at a full price with an unsettled competitive picture and no margin of safety.
43/100
Harmonic Drive Systems: A Zen Horizon Framework Deep Dive
Harmonic Drive Systems (6324.TSE) is the global leader in harmonic reducers, or strain wave gearing, with roughly 58% global share by sales value and more than 70% share in the high-end market. Its products are de facto standard components for industrial robot wrist and forearm joints, semiconductor equipment, aerospace precision axes, and the purest picks-and-shovels exposure to humanoid robot rotary joints. Research rating Watch: a great company at an uninvestable price, with real but eroding moat quality and negative margin of safety.
48/100
39Buffett
Siemens Energy Deep Research under the Zen Horizon Framework
Siemens Energy (ENR.XETRA) is a global full-stack power technology leader spun out of Siemens AG in 2020, spanning generation, transmission, industrial decarbonization, and wind through Siemens Gamesa. The company has reversed sharply from the Siemens Gamesa turbine-quality crisis and a FY2023 net loss of €4.59 billion to FY2025 net income of €1.685 billion and pre-tax free cash flow of €4.66 billion. Research rating Hold: a wide-moat crisis turnaround with real structural exposure to AI power demand and grid investment, but valuation already prices in much of the upside.
39/100
Recursion Pharmaceuticals: A Zen Horizon Framework Deep Dive
Recursion Pharmaceuticals (RXRX.US) is the flagship AI drug-discovery name: the largest and most broadly integrated AI-native drug company globally, with Exscientia added in 2024 to fill the precision-chemistry gap. The core thesis is a hybrid of an AI drug-discovery platform and an in-house biotech pipeline, backed by deep partnerships with NVIDIA, Roche/Genentech, Bayer, Sanofi, and others, yet still dependent on unpredictable collaboration milestones with no product revenue. Report rating Watch: real infrastructure assets and a heavily reset valuation deserve close tracking, but NVIDIA exited its stake by the end of 2025 and founder CEO Chris Gibson has stepped down while the platform remains clinically unproven.
46/100
73Buffett
Fabrinet Zen Horizon Framework Deep-Dive Research
Fabrinet (FN.US) is the hidden-champion contract manufacturer behind optical interconnects for AI data centers. As the world's largest independent precision optical EMS provider, it builds 800G/1.6T optical transceivers and optical components for NVIDIA (27.6% of FY2025 revenue), Cisco, Lumentum, Coherent, Ciena, and others, making it a picks-and-shovels foundry for AI compute networks, while its contract-manufacturing model structurally caps gross margin at about 12%, leaves it cost-plus with almost no pricing power, and makes optical communications 73% of revenue. Rating Watch: a high-quality execution story with strong AI exposure, but thin margins, customer concentration, CPO disintermediation risk, and a rich valuation argue for patience.
48/100
27Buffett
Cheniere Energy Zen Horizon Framework Deep-Dive Research
Cheniere Energy is the master gate for U.S. natural gas exports, a textbook-quality fee-based infrastructure business built on 20-year take-or-pay contracts that earn stable tolling fees largely decoupled from gas prices. Roughly 95% of capacity is locked under long-term contracts with a weighted remaining term of about 15 years, after the company transformed its 2008 Sabine Pass LNG import terminal into an export platform and became the largest U.S. and second-largest global LNG operator. Research rating Hold: a high-quality asset at a fair but not cheap valuation, with a thin margin of safety amid temporary 2026 Iran-Qatar war premium, a major LNG supply wave, and a 2030s recontracting cliff.